-The Times of India NEW DELHI: The seventh AIIMS-like institute will come up at Rae Bareilly - Congress president Sonia Gandhi's parliamentary constituency - soon. Union health minister Ghulam Nabi Azad announced this on Thursday while addressing the convocation ceremony at AIIMS, Delhi. Azad said that land for the new AIIMS project has been acquired already. "We have acquired land for building AIIMS in Rae Bareilley and tendering process for construction is...
More »SEARCH RESULT
Total Matching Records found : 60
Low-end wart in FDI in research -GS Mudur
-The Telegraph New Delhi: Foreign corporations have created over 247,000 jobs through research and development (R&D) investments in India over the past decade, but most of the activities appear relatively unimportant with little long-term gains , researchers have said. The study, described as the first comprehensive assessment of foreign direct investment (FDI) in R&D, has challenged suggestions by Indian science policy makers and foreign corporations a decade ago that turning India into...
More »Do BPL families get their due at Cancer centres?-Omar Rashid
-The Hindu Allahabad: With her legs crossed and hands folded, 10-year-old Shivani sits quietly on her bed at the Kamla Nehru Regional Cancer Centre's (RCC) Jawahar ward, named after the country's first Prime Minister. "I want to grow up to be a doctor. I like playing the doctor and using needles (injections)," she replied to this correspondent's query. Shivani's father Suresh Kesharwani, mother Bimla and elder brother Rohit (17) look on anxiously. Shivani...
More »The Cost of Drugs: Beyond the Supreme Court Order -Sanjay Nagral
-Economic and Political Weekly While the Supreme Court decision in the recent Novartis case has cleared the way for production of generic drugs in India, doctors have to prescribe cheaper alternatives to costly brands if patients with limited means are to benefit. What is being hailed as a victory in the struggle for affordable medicines in the country will actually be one only when there is a pro-patient slant to the...
More »Supreme Court rules for cheap cancer drug -Subodh Varma
-The Times of India The Supreme Court on Monday rejected pharma giant Novartis AG's plea to preserve its patent over a life-saving cancer drug, Glivec, drawing a huge sigh of relief from thousands of patients in India and in dozens of developing countries as the fear of an almost 15-fold escalation of drug costs receded. It is the biggest setback for multinational pharma companies, which have been denied patent protection...
More »
